Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
Rio De Janeiro, Brazil
Instituto de pesquisa científica no Rio de Janeiro
About Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
During the past decade, Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI) conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on
average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
2020-02-28
2024-03-29
Recruiting
105
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
According to Clinical.Site data, the most researched conditions in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)" are
"Multiple Myeloma" (3 trials), "Relapsed or Refractory Multiple Myeloma" (2 trials), "Amyloidosis" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Castration-Resistant Prostatic Cancer" (1 trials). Many other conditions were trialed in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
Most popular intervention types in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)" are "Drug" (12 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (3 trials), "Daratumumab" (3 trials), "Dexamethasone" (3 trials), "Pomalidomide" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
The vast majority of trials in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)" are
10 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)
Currently, there are NaN active trials in "Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI)".
undefined are not yet recruiting,
6 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI),
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".